A prize for the health organization that best uses and promotes the FHIR International Patient Summary (IPS). The competition closes on 15th May 2019 for The Trillium II Prize.
The prize that will award the health organisation that, in the opinion of the panel of judges, has done the most to use and promote FHIR International Patient Summary (IPS) for international medical information exchanges.
Trillium II builds on previous recommendations to put IPS standards at the core of a global community for digital health innovation, with the aim of advancing patient safety and trust by bridging the gap between strategic intent and capability to deliver interoperability at a global scale.
The competition will close on 15th May 2019 and the winners will be announced at an appropriate event in Europe a month thereafter. Furthermore, in addition to the promotional benefits from winning the prize, there will be a cash award of €1,000.
How to register?
All candidates are required to send a registration request to MedCom (Lene Taustrup, lta@medcom.dk) in order to ensure that they have immediate access to the online registration form and all the updates to the definition of the IPS, and other relevant data that are produced during the competition period, so that they are working from a level playing field. Entries should be in English only.
In the online form the following information must be provided according to the following format:
- Applicant details – name, organisation, address including country, other contact details, organisation type, ultimate organisation owner/s.
- Organisational role – how your organisation can use the IPS to improve international healthcare delivery; who you have worked with to do this (if any other organisation(s). Max 300 words
- IPS implementation details – how you have put the IPS to use; the type of healthcare service you are using it in; the specifics of the application. Max 300 words.
- Results – what the results have been so far, ideally quantitively in terms of people affected, benefit received and improved patient outcomes, including who has verified the results, otherwise qualitatively. Max 300 words.
- The future – extrapolate into the future what benefits your use of the ILS will deliver – please give a rationale and justification for your projection so the judges can decide how likely it is to happen. Max 300 words
All the key documents relevant to the IPS that have been finalised to date are available for download.
For more information please contact Charles Lowe at charles.lowe@dhaca.org.uk and follow the official hashtag #TrilliumIIPrize.
